1.54 USD
▼-0.02-2.53%
盘后 1.49 -5.70%
2026-08-03
市值
$9.82M
市盈率
—
EPS
-1.55
股息率
—
52 周区间
1.43 – 9.48
成交量
70.44K
Beta
3.60
目标价
—
52W 低 1.4352W 高 9.48
价格走势
公司简介
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.